Xconomy: Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill?
Summary
Opinion (Page 2 of 2) have “seen a littler further” if his studies in mathematics, optics, celestial mechanics, and gravitation were based on the work of contemporaries and predecessors who had produced mostly bad science?The process through which many scientific advances are made came to mind after reading an alarming paper recently published in Nature by C. Glenn Begley and Lee M. Ellis.The authors reported that significant efforts were made to reproduce the results found in 53 “landmark” cancer research papers as part of a corporate R&D program at Amgen.Would their investors view the money spent replicating published results as a worthwhile use of limited financial resources at the expense of just pushing ahead with the program?A number of Big Pharma companies (e.g. Pfizer, Merck KGaA, Novartis, and AstraZeneca) recently moved jobs to the Boston area, the largest U.S. biotech hub, as they restructured and downsized their R&D programs.
Classifications
AskAI Classifications
LabelsLinked Companies
